Overview
- 10 inspections across 10 sites are on record.
- 5 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2010-08-13.
At a glance
Inspections
10
Sites
10
Observations
5
Career since
Aug 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jinhe Biotechnology Co., Ltd. | 13 Aug 2010 | On file | |
| Sichuan Credit (Chemwerth) Pharmaceutical Co. Ltd. | 6 Aug 2010 | On file | |
| Chongqing Pharma Research Institute Co., Ltd. | 30 Jul 2010 | On file | |
| Livzon New North River Pharmaceutical Co., Ltd. | 23 Jul 2010 | On file | |
| Kawasumi Laboratories (Thailand) Co., Ltd. | 6 Aug 2009 |
Sites inspected
Jinhe Biotechnology Co., Ltd.Hohhot City, China1 insp.
Sichuan Credit (Chemwerth) Pharmaceutical Co. Ltd.Luzhou, China1 insp.
Chongqing Pharma Research Institute Co., Ltd.Zhongqing, China1 insp.
Livzon New North River Pharmaceutical Co., Ltd.Qingyuan, China1 insp.
Kawasumi Laboratories (Thailand) Co., Ltd.Khlong Luang, Thailand1 insp.
Co-investigators
Investigators who share inspections with this person.
Farhana Khan4 shared
Full investigator report
Get the verbatim findings behind Sumit Sen's 5 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site